ClinicalTrials.Veeva

Menu

Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke

J

Jacobs institute

Status

Completed

Conditions

Ischemic Stroke

Treatments

Device: neurological thrombectomy device is an investigational device.

Study type

Interventional

Funder types

Other

Identifiers

NCT05074186
DELPHI D001-PRT21-026

Details and patient eligibility

About

The Jacobs Institute is participating in a Sponsor Investigator study designed to collect prospective clinical evidence to evaluate the use of a neurological thrombectomy device for clot retrieval in acute ischemic patients

Full description

The neurological thrombectomy device is an investigational device

Enrollment

8 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

at least 18 years of age at time of consent Has baseline National Institutes of Health Stroke Scale (NIHSS) ≥ 8; Able to be treated within 8 hours of stroke symptom onset or Last Known Normal (LKN);

Exclusion criteria

Cannot provide consent or legally authorized representative not available to provide consent

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

neurological thrombectomy device
Experimental group
Description:
Revascularization device is an investigational device.
Treatment:
Device: neurological thrombectomy device is an investigational device.

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Gay, CCRP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems